Revvity, Inc. (NYSE: RVTY), released its third-quarter 2025 financial results, revealing a mix of progress and challenges. The company reported $699 million in revenue, representing modest year-over-year growth, while adjusted earnings per share exceeded expectations. Management affirmed its organic growth targets and raised full-year EPS guidance, signaling confidence in Revvity’s long-term strategy.
Earnings Outshine Revenue Despite a Slight Revenue Shortfall
Revvity reported a revenue of $699 million for the third quarter of 2025, marking a 2% increase from the same period last year. However, the revenue fell short of expectations, reaching $699.98 million.
The adjusted earnings per share (EPS) stood at $0.40, down from $0.77 in the previous year. Notably, the adjusted EPS for continuing operations reached $1.18, surpassing the anticipated $1.14. This strong performance suggests a more efficient execution even with the revenue shortfall.
While the overall revenue did not meet projections, Revvity demonstrated resilience in its adjusted earnings.
Life Sciences and Diagnostics Show Growth
The Life Sciences segment reported $343 million in revenue, a slight increase from the previous year. Diagnostics saw revenue grow to $356 million, an uptick from $345 million. These segments showed positive trends, with the Diagnostics segment achieving 2% organic growth.
However, both segments experienced decreased adjusted operating income and profit margins compared to the previous year, highlighting areas for potential improvement.
Strategic Outlook: Growth Goals Reaffirmed and EPS Raised
Revvity reaffirmed its full-year revenue guidance of $2.83 billion to $2.88 billion, factoring in recent currency exchange rate fluctuations.
The company’s organic growth target remains at 2% to 4%, indicating confidence in the company’s business strategies and market position. Furthermore, Revvity raised its adjusted EPS guidance for the full year to between $4.90 and $5.00, reflecting a positive outlook on achieving strong financial results.
Revvity’s strategic initiatives will be instrumental in driving future growth. The company expects innovations and partnerships to play a key role in this expansion. Revvity’s management expressed optimism about the company’s trajectory, highlighting its potential for continued success in 2026 and beyond. A new $1 billion share repurchase program further demonstrates confidence in the company’s financial health and commitment to returning value to shareholders.
In summary, Revvity maintains a balanced approach to navigating market conditions while prioritizing long-term growth opportunities. The company’s emphasis on innovation and strategic execution positions it well for success and sustainable growth.
Disclaimer: This article was written by an AI and does not hold or have a position in any of the securities discussed. All stock prices were quoted at the time of writing.